The available literature provides few studies on the effectiveness of methylphenidate in improving quality of life in individuals with ADHD. Objective: To assess the effectiveness of Methyphenidate OROS formulation (OROS MPH) through QoL in adults with ADHD. Method: A 12-week, multicenter, open-label trial involving 60 patients was used. The measures used were Adult Self-Rating Scale, Adult ADHD Quality of Life Scale (AAQoL), State and Trait Anxiety Inventory (STAI), Hamilton Depression Rating Scale (HAM-D), Clinical Global Impression (CGI), and safety measures. A significance statistic level of 5% was adopted. Results: Analyses included 60 patients (66.7% male; M age = 31.1 years) for safety and 58 patients for effectiveness. All AAQoL subscales improved from baseline to Week 12 (p < .0001), as well as the Total AAQoL (p < .0001). A significant reduction on Clinical Global Impression–Improvement (CGI-I), HAM-D, STAI, and ASRS scores was observed (p < .0001). No serious adverse event was reported. Conclusion: Treatment of adult ADHD patients with OROS MPH improves QoL.
AbleS. L.JohnstonJ. A.AdlerL. A.SwindleR. W. (2007). Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychological Medicine, 37, 97-107.
2.
AdlerL. A.SuttonV. K.MooreR. J.DietrichA. P.ReimherrF. W.SangalB.. . .AllenA. J. (2006). Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. Journal of Clinical Psychopharmacology, 26, 648-652.
3.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4.
BrodM.JohnstonJ.AbleS.SwindleR. (2006). Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): A disease-specific quality-of-life measure. Quality of Life Research, 15, 117-129.
5.
FaraoneS.SpencerT.AleardiM.PaganoC.BiedermanJ. (2004). Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 24, 24-29.
6.
GathjeR. A.LewandowskiL.GordonM. (2008). The role of impairment in the diagnosis of ADHD. Journal of Attention Disorders, 11, 529-537.
7.
GillT. M.FeinsteinA. R. (1994). A critical appraisal of the quality of quality-of-life measurements. Journal of the American Medical Association, 272, 619-626.
8.
GoksoyrP. K.NottestadJ. A. (2008). The burden of untreated ADHD among adults: The role of stimulant medication. Addictive Behaviors, 33, 342-346.
9.
GoodmanD. W.GinsbergL.WeislerR. H.CutlerA. J.HodgkinsP. (2005). An interim analysis of the quality of life, effectiveness, safety and tolerability (QUEST) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectrums, 10, 26-34.
10.
GrevetE. H.BauC. H.SalgadoC. A.FicherA.VictorM. M.GarciaC.. . .Belmonte-De-AbreuP. (2005). Concordância entre observadores para o diagnóstico em adultos do transtorno de déficit de atenção/hiperatividade e transtorno de oposição desafiante utilizando o K-SADS-E. [Interrater reliability for diagnosis in adults of attention deficit hyperactivity disorder and oppositional defiant disorder using K-SADS-E] Arquivos de Neuropsiquiatria, 63, 307-310.
11.
KesslerR.AdlerL.BarkleyR.BiedermanJ.ConnersC.DemlerO.. . .ZaslavskyA. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723.
12.
KnouseL. E.MitchellJ. T.BrownL. H.SilviaP. J.KaneM. J.Myin-GermeysI.KwapilT. R. (2008). The expression of adult ADHD symptoms in daily life: An application of experience sampling methodology. Journal of Attention Disorders, 11, 652-663.
13.
MattosP.PalminiA.SalgadoC. A.SegenreichD.GrevetE.OliveiraI.. . .LimaP. (2006). Painel brasileiro de especialistas sobre diagnóstico do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos [Brazilian consensus of specialists on the diagnosis of attention-deficit/hyperactivity disorder in adults]. Rev Psiquiatr RS, 28, 50-60.
14.
MattosP.SegenreichD.DiasG. M.NazarB.SaboyaE.BrodM. (2011). Construct reliability and validity of the Portuguese version of the Adult ADHD Quality of Life Questionnaire—AAQoL. Revista de Psiquiatria Clínica, 38(3), 91-96.
15.
MattosP.SegenreichD.DiasG. M.NazarB.SaboyaE.CoutinhoG.BrodM. (2011). Semantic validation of the Portuguese version of the Adult ADHD Quality of Life Questionnaire—AAQoL. Revista de Psiquiatria Clínica, 38(3), 87-90.
16.
MattosP.SegenreichD.SaboyaE.LouzãM.DiasG.RomanoM. (2006). Adaptação transcultural para o português da escala Adult Self Report Scale para avaliação do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos. [Transcultural adaptation of the Adult Self-Report Scale into portuguese for evaluation of adult attention-deficit/hyperactivity disorder (ADHD)] Revista de Psiquiatria Clínica, 33, 188-194.
17.
SzobotC. M.RohdeL. A.KatzR.RuaroP.SchaeferT.WalcherM.. . .PechanskyF. (2008). A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Brazilian Journal of Medical and Biological Research, 41, 250-257.
